Precision Vaccinology Overview

Principles

Definition

Precision vaccinology is a research field and methodological approach focused on the personalized design, development, and application of vaccines. It leverages individual genetic, immunological, and other biological profiles to tailor immunization strategies, aiming to optimize vaccine efficacy, enhance safety, and broaden the scope of vaccinology beyond infectious diseases towards the principles of precision medicine.

Ontological type

Core Principles

Technological Platforms

Biomarkers and Stratification

Key developments

Key Figures

Route and Field Immunogenicity era

Robert M. Chanock [1] was a leading figure at Johns Hopkins University [3] and the University of Maryland, Baltimore [4] during the Route and Field Immunogenicity era. His key contributions in this era centered on the epidemiologic study AN EPIDEMIOLOGIC STUDY OF ALTERED CLINICAL REACTIVITY TO RESPIRATORY SYNCYTIAL (RS) VIRUS INFECTION IN CHILDREN PREVIOUSLY VACCINATED WITH AN INACTIVATED RS VIRUS VACCINE [7], illustrating how field-based evaluation of vaccines can reveal shifts in antibody profiles and protective outcomes in real-world settings. Stanley A. Plotkin [2] was affiliated with the University of Pennsylvania [5] and the University of North Carolina at Chapel Hill [6] during this era. His key contributions include Field Evaluation of a Human Anthrax Vaccine [8], which linked laboratory immunogenicity to population-level protection and guided practical dosing and attenuation strategies for field applicability.

Antigen Design and Conjugation era

Robert G. Webster [1] was a central figure in the antigen design and conjugation era, with affiliations spanning University of California, San Francisco [3] and United States Military Academy [4]. His work, notably the DNA vaccines paper DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations [6], contributed a paradigm shift by showing viable, route-diverse gene-based immunization, a key step for antigen design and conjugation strategies in this era. Harriet L. Robinson [2] was a leading figure aligned with Harvard University [5] and University of California, San Francisco [3] during this era. Her key contributions center on DNA vaccines work, notably the DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations [6], highlighting gene-based immunization approaches that informed age-appropriate design choices in antigen engineering during this era.

Policy-driven Precision Vaccinology era

Lauri E. Markowitz[1], affiliated with the University of Washington[3] and the University of California, Los Angeles[4], is a leading figure in precision vaccinology. Her key contributions include Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices[7], National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2014[8], and Use of a 2-Dose Schedule for Human Papillomavirus Vaccination — Updated Recommendations of the Advisory Committee on Immunization Practices[9], which provided crucial evidence for dose optimization and age-based schedules in this era. David Yankey[2], affiliated with Oak Ridge Associated Universities[5] and Oak Ridge Institute for Science and Education[6], contributed to surveillance-informed public health policy. His work on National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2014[8], Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014—United States[10], and National, State, and Selected Local Area Vaccination Coverage Among Children Aged 19–35 Months — United States, 2014[11] provided essential real-world data that informed population-level policy and programmatic decisions in this era.